| abstract |
Disclosed is a pharmaceutical system for the prevention and / or treatment of viral infections, in particular RNA minus strand viral infections, preferably influenza infections, and a test system for identifying appropriate active substances thereof. Preparation of a pharmaceutical composition for the prevention and / or treatment of at least one viral disease, characterized in that it inhibits cellular caspases, in particular caspase-3, such that the active substance inhibits viral growth and its suitability Active active substance identification test system. |